The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded an Indefinite Delivery Contract (IDC) to Optum Pharmacy 801, Inc. (doing business as Avella Specialty Pharmacy), a subsidiary of UnitedHealth Group Incorporated. The contract, valued at $4,000,000 over the 5-year period of performance from May 1, 2024 to September 30, 2028, is for contingency hazardous pharmaceutical compounding services to support oncology and infusion treatment programs at the VA Sierra Nevada Health Care System in Reno, Nevada.
Avella, a 503A certified pharmacy, will provide specialized compounding services for customized chemotherapy agents, hazardous sterile preparations, intravenous solutions, and other medications based on patient-specific orders. The contract includes a base period and four one-year option periods, allowing the VA to issue task orders and calls for Avella's services as needed across its national health system. The contract is not associated with any set-aside designations, reflecting Avella's status as a large, experienced government contractor in the specialized pharmacy services domain.
Generated 1/8/25, 9:03 AM